nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—DRD4—conduct disorder	0.395	0.485	CbGaD
Loxapine—SLC6A4—conduct disorder	0.237	0.291	CbGaD
Loxapine—HTR2A—conduct disorder	0.182	0.224	CbGaD
Loxapine—SLC6A2—autonomic nervous system—conduct disorder	0.00487	0.14	CbGeAlD
Loxapine—HTR7—autonomic nervous system—conduct disorder	0.00469	0.135	CbGeAlD
Loxapine—HTR2A—autonomic nervous system—conduct disorder	0.00293	0.0843	CbGeAlD
Loxapine—HTR5A—brain—conduct disorder	0.00291	0.084	CbGeAlD
Loxapine—DRD4—brain—conduct disorder	0.00144	0.0416	CbGeAlD
Loxapine—HTR1E—brain—conduct disorder	0.00124	0.0359	CbGeAlD
Loxapine—CHRM4—brain—conduct disorder	0.00109	0.0314	CbGeAlD
Loxapine—DRD3—brain—conduct disorder	0.00101	0.0292	CbGeAlD
Loxapine—HTR6—brain—conduct disorder	0.000976	0.0281	CbGeAlD
Loxapine—DRD5—brain—conduct disorder	0.00095	0.0274	CbGeAlD
Loxapine—HRH2—brain—conduct disorder	0.000892	0.0257	CbGeAlD
Loxapine—CHRM5—brain—conduct disorder	0.000852	0.0246	CbGeAlD
Loxapine—Asenapine—DRD4—conduct disorder	0.000827	0.109	CrCbGaD
Loxapine—ADRA1B—brain—conduct disorder	0.000779	0.0225	CbGeAlD
Loxapine—DRD1—brain—conduct disorder	0.000726	0.0209	CbGeAlD
Loxapine—HTR3A—brain—conduct disorder	0.000701	0.0202	CbGeAlD
Loxapine—HTR1B—brain—conduct disorder	0.000588	0.017	CbGeAlD
Loxapine—CHRM2—brain—conduct disorder	0.000585	0.0169	CbGeAlD
Loxapine—SLC6A3—brain—conduct disorder	0.000583	0.0168	CbGeAlD
Loxapine—HTR1D—brain—conduct disorder	0.00057	0.0164	CbGeAlD
Loxapine—Chlordiazepoxide—GABRA2—conduct disorder	0.000569	0.0752	CrCbGaD
Loxapine—HTR2C—brain—conduct disorder	0.000564	0.0163	CbGeAlD
Loxapine—ADRB1—brain—conduct disorder	0.000553	0.016	CbGeAlD
Loxapine—SLC6A4—brain—conduct disorder	0.000535	0.0154	CbGeAlD
Loxapine—CHRM1—brain—conduct disorder	0.000533	0.0154	CbGeAlD
Loxapine—Asenapine—SLC6A4—conduct disorder	0.000496	0.0656	CrCbGaD
Loxapine—Alprazolam—GABRA2—conduct disorder	0.000482	0.0637	CrCbGaD
Loxapine—CHRM3—brain—conduct disorder	0.000477	0.0137	CbGeAlD
Loxapine—HTR1A—brain—conduct disorder	0.000475	0.0137	CbGeAlD
Loxapine—SLC6A2—brain—conduct disorder	0.000471	0.0136	CbGeAlD
Loxapine—Olanzapine—DRD4—conduct disorder	0.00046	0.0608	CrCbGaD
Loxapine—HTR7—brain—conduct disorder	0.000454	0.0131	CbGeAlD
Loxapine—ADRA1A—brain—conduct disorder	0.000438	0.0126	CbGeAlD
Loxapine—DRD2—brain—conduct disorder	0.000429	0.0124	CbGeAlD
Loxapine—ADRA2C—brain—conduct disorder	0.000417	0.012	CbGeAlD
Loxapine—Fludiazepam—GABRA2—conduct disorder	0.000389	0.0514	CrCbGaD
Loxapine—Asenapine—HTR2A—conduct disorder	0.000381	0.0504	CrCbGaD
Loxapine—Prazepam—GABRA2—conduct disorder	0.00038	0.0502	CrCbGaD
Loxapine—Amoxapine—DRD4—conduct disorder	0.000366	0.0484	CrCbGaD
Loxapine—HRH1—brain—conduct disorder	0.000339	0.00977	CbGeAlD
Loxapine—Temazepam—GABRA2—conduct disorder	0.000339	0.0447	CrCbGaD
Loxapine—ADRA2A—brain—conduct disorder	0.000333	0.00959	CbGeAlD
Loxapine—HTR2A—brain—conduct disorder	0.000283	0.00816	CbGeAlD
Loxapine—Diazepam—GABRA2—conduct disorder	0.000281	0.0372	CrCbGaD
Loxapine—Quetiapine—DRD4—conduct disorder	0.000279	0.0369	CrCbGaD
Loxapine—Trazodone—SLC6A4—conduct disorder	0.000267	0.0352	CrCbGaD
Loxapine—Clozapine—DRD4—conduct disorder	0.00024	0.0317	CrCbGaD
Loxapine—Zuclopenthixol—HTR2A—conduct disorder	0.000223	0.0294	CrCbGaD
Loxapine—Amoxapine—SLC6A4—conduct disorder	0.00022	0.029	CrCbGaD
Loxapine—Cyproheptadine—HTR2A—conduct disorder	0.000219	0.0289	CrCbGaD
Loxapine—Olanzapine—HTR2A—conduct disorder	0.000212	0.028	CrCbGaD
Loxapine—Trazodone—HTR2A—conduct disorder	0.000205	0.0271	CrCbGaD
Loxapine—Thiothixene—HTR2A—conduct disorder	0.000192	0.0254	CrCbGaD
Loxapine—Amoxapine—HTR2A—conduct disorder	0.000169	0.0223	CrCbGaD
Loxapine—Trifluoperazine—HTR2A—conduct disorder	0.000133	0.0175	CrCbGaD
Loxapine—Quetiapine—HTR2A—conduct disorder	0.000129	0.017	CrCbGaD
Loxapine—Clozapine—HTR2A—conduct disorder	0.000111	0.0146	CrCbGaD
Loxapine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	4.69e-05	0.000329	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—CGA—conduct disorder	4.69e-05	0.000328	CbGpPWpGaD
Loxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	4.68e-05	0.000328	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—HTR2A—conduct disorder	4.68e-05	0.000327	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	4.65e-05	0.000326	CbGpPWpGaD
Loxapine—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	4.65e-05	0.000326	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—CGA—conduct disorder	4.59e-05	0.000321	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—CGA—conduct disorder	4.52e-05	0.000316	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—DRD4—conduct disorder	4.48e-05	0.000313	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—DRD4—conduct disorder	4.47e-05	0.000313	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—CGA—conduct disorder	4.46e-05	0.000312	CbGpPWpGaD
Loxapine—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	4.46e-05	0.000312	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—DRD4—conduct disorder	4.45e-05	0.000311	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—DRD4—conduct disorder	4.44e-05	0.000311	CbGpPWpGaD
Loxapine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	4.42e-05	0.000309	CbGpPWpGaD
Loxapine—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	4.41e-05	0.000308	CbGpPWpGaD
Loxapine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	4.37e-05	0.000306	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—DRD4—conduct disorder	4.35e-05	0.000305	CbGpPWpGaD
Loxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	4.35e-05	0.000304	CbGpPWpGaD
Loxapine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	4.34e-05	0.000304	CbGpPWpGaD
Loxapine—HTR1E—Signaling by GPCR—HTR2A—conduct disorder	4.28e-05	0.000299	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CGA—conduct disorder	4.27e-05	0.000299	CbGpPWpGaD
Loxapine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	4.25e-05	0.000297	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—DRD4—conduct disorder	4.22e-05	0.000296	CbGpPWpGaD
Loxapine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	4.21e-05	0.000295	CbGpPWpGaD
Loxapine—HRH2—GPCR downstream signaling—HTR2A—conduct disorder	4.2e-05	0.000294	CbGpPWpGaD
Loxapine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	4.19e-05	0.000293	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—DRD4—conduct disorder	4.19e-05	0.000293	CbGpPWpGaD
Loxapine—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	4.17e-05	0.000292	CbGpPWpGaD
Loxapine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	4.08e-05	0.000285	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CGA—conduct disorder	4.07e-05	0.000285	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—CGA—conduct disorder	4.05e-05	0.000283	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—DRD4—conduct disorder	4.05e-05	0.000283	CbGpPWpGaD
Loxapine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	4.01e-05	0.000281	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CGA—conduct disorder	4.01e-05	0.000281	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—DRD4—conduct disorder	3.87e-05	0.000271	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—DRD4—conduct disorder	3.86e-05	0.00027	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	3.82e-05	0.000267	CbGpPWpGaD
Loxapine—HRH2—Signaling by GPCR—HTR2A—conduct disorder	3.81e-05	0.000267	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—DRD4—conduct disorder	3.8e-05	0.000266	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—WASF1—conduct disorder	3.79e-05	0.000265	CbGpPWpGaD
Loxapine—DRD5—Signaling by GPCR—HTR2A—conduct disorder	3.79e-05	0.000265	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—WASF1—conduct disorder	3.78e-05	0.000265	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	3.78e-05	0.000265	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—WASF1—conduct disorder	3.76e-05	0.000263	CbGpPWpGaD
Loxapine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	3.7e-05	0.000259	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—WASF1—conduct disorder	3.68e-05	0.000257	CbGpPWpGaD
Loxapine—DRD2—Circadian rythm related genes—EP300—conduct disorder	3.67e-05	0.000257	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CGA—conduct disorder	3.66e-05	0.000256	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	3.65e-05	0.000255	CbGpPWpGaD
Loxapine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	3.63e-05	0.000254	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	3.63e-05	0.000254	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CGA—conduct disorder	3.62e-05	0.000253	CbGpPWpGaD
Loxapine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	3.62e-05	0.000253	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—WASF1—conduct disorder	3.62e-05	0.000253	CbGpPWpGaD
Loxapine—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	3.61e-05	0.000253	CbGpPWpGaD
Loxapine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	3.59e-05	0.000251	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—CGA—conduct disorder	3.58e-05	0.000251	CbGpPWpGaD
Loxapine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	3.58e-05	0.00025	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—WASF1—conduct disorder	3.57e-05	0.00025	CbGpPWpGaD
Loxapine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	3.57e-05	0.000249	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	3.53e-05	0.000247	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CGA—conduct disorder	3.5e-05	0.000245	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CGA—conduct disorder	3.48e-05	0.000243	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	3.48e-05	0.000243	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—DRD4—conduct disorder	3.47e-05	0.000243	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—DRD4—conduct disorder	3.45e-05	0.000241	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	3.43e-05	0.00024	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—DRD4—conduct disorder	3.43e-05	0.00024	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—WASF1—conduct disorder	3.42e-05	0.000239	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CGA—conduct disorder	3.38e-05	0.000237	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CGA—conduct disorder	3.33e-05	0.000233	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	3.32e-05	0.000232	CbGpPWpGaD
Loxapine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	3.31e-05	0.000232	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	3.3e-05	0.000231	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—CGA—conduct disorder	3.29e-05	0.00023	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—WASF1—conduct disorder	3.26e-05	0.000228	CbGpPWpGaD
Loxapine—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	3.22e-05	0.000225	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—WASF1—conduct disorder	3.22e-05	0.000225	CbGpPWpGaD
Loxapine—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	3.21e-05	0.000225	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	3.21e-05	0.000224	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	3.21e-05	0.000224	CbGpPWpGaD
Loxapine—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	3.19e-05	0.000223	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	3.16e-05	0.000221	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	3.15e-05	0.000221	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	3.15e-05	0.00022	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	3.14e-05	0.000219	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	3.13e-05	0.000219	CbGpPWpGaD
Loxapine—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	3.13e-05	0.000219	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	3.1e-05	0.000217	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	3.09e-05	0.000216	CbGpPWpGaD
Loxapine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	3.08e-05	0.000215	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CGA—conduct disorder	3.07e-05	0.000215	CbGpPWpGaD
Loxapine—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	3.04e-05	0.000212	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CGA—conduct disorder	3.02e-05	0.000211	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CGA—conduct disorder	3.01e-05	0.000211	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CGA—conduct disorder	3e-05	0.00021	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CGA—conduct disorder	3e-05	0.00021	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CGA—conduct disorder	2.97e-05	0.000208	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CGA—conduct disorder	2.96e-05	0.000207	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—WASF1—conduct disorder	2.93e-05	0.000205	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—HTR2A—conduct disorder	2.92e-05	0.000204	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—HTR2A—conduct disorder	2.92e-05	0.000204	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—DRD4—conduct disorder	2.91e-05	0.000204	CbGpPWpGaD
Loxapine—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	2.91e-05	0.000203	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	2.9e-05	0.000203	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—HTR2A—conduct disorder	2.9e-05	0.000203	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	2.9e-05	0.000203	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	2.87e-05	0.000201	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	2.86e-05	0.0002	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—DRD4—conduct disorder	2.86e-05	0.0002	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	2.85e-05	0.000199	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—DRD4—conduct disorder	2.84e-05	0.000199	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	2.84e-05	0.000199	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	2.81e-05	0.000197	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	2.8e-05	0.000196	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—WASF1—conduct disorder	2.8e-05	0.000196	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	2.79e-05	0.000196	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—WASF1—conduct disorder	2.79e-05	0.000195	CbGpPWpGaD
Loxapine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	2.77e-05	0.000194	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	2.76e-05	0.000193	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CGA—conduct disorder	2.75e-05	0.000192	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	2.73e-05	0.000191	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	2.71e-05	0.00019	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	2.67e-05	0.000187	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—DRD4—conduct disorder	2.65e-05	0.000185	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—DRD4—conduct disorder	2.64e-05	0.000185	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	2.64e-05	0.000185	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—DRD4—conduct disorder	2.63e-05	0.000184	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	2.61e-05	0.000182	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—DRD4—conduct disorder	2.57e-05	0.00018	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—HTR2A—conduct disorder	2.53e-05	0.000177	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	2.52e-05	0.000176	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—DRD4—conduct disorder	2.5e-05	0.000175	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	2.49e-05	0.000174	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	2.48e-05	0.000174	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—EP300—conduct disorder	2.48e-05	0.000173	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	2.47e-05	0.000173	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—WASF1—conduct disorder	2.46e-05	0.000172	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—WASF1—conduct disorder	2.42e-05	0.000169	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—WASF1—conduct disorder	2.42e-05	0.000169	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—WASF1—conduct disorder	2.41e-05	0.000169	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—WASF1—conduct disorder	2.4e-05	0.000168	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—DRD4—conduct disorder	2.39e-05	0.000167	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	2.38e-05	0.000167	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—WASF1—conduct disorder	2.38e-05	0.000166	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	2.37e-05	0.000166	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	2.37e-05	0.000166	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	2.3e-05	0.000161	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—DRD4—conduct disorder	2.28e-05	0.000159	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	2.27e-05	0.000159	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	2.26e-05	0.000158	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—HTR2A—conduct disorder	2.25e-05	0.000157	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—DRD4—conduct disorder	2.25e-05	0.000157	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	2.24e-05	0.000157	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—HTR2A—conduct disorder	2.24e-05	0.000156	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	2.2e-05	0.000154	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	2.16e-05	0.000151	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	2.15e-05	0.000151	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	2.09e-05	0.000146	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	2.09e-05	0.000146	CbGpPWpGaD
Loxapine—ADRA2B—Hemostasis—EP300—conduct disorder	2.07e-05	0.000145	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	2.06e-05	0.000144	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	2.05e-05	0.000144	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—DRD4—conduct disorder	2.05e-05	0.000143	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	2.05e-05	0.000143	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	2.04e-05	0.000143	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	2.03e-05	0.000142	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	2.02e-05	0.000141	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	2.01e-05	0.000141	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—DRD4—conduct disorder	1.96e-05	0.000137	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—DRD4—conduct disorder	1.95e-05	0.000136	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—EP300—conduct disorder	1.93e-05	0.000135	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	1.9e-05	0.000133	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	1.89e-05	0.000133	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	1.87e-05	0.000131	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	1.87e-05	0.00013	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	1.86e-05	0.00013	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	1.86e-05	0.00013	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	1.85e-05	0.00013	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	1.83e-05	0.000128	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	1.83e-05	0.000128	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—COMT—conduct disorder	1.83e-05	0.000128	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—MAOA—conduct disorder	1.81e-05	0.000127	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—HTR2A—conduct disorder	1.73e-05	0.000121	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—HTR2A—conduct disorder	1.72e-05	0.000121	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—DRD4—conduct disorder	1.72e-05	0.00012	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—HTR2A—conduct disorder	1.71e-05	0.00012	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	1.7e-05	0.000119	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—DRD4—conduct disorder	1.69e-05	0.000118	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—DRD4—conduct disorder	1.69e-05	0.000118	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—DRD4—conduct disorder	1.68e-05	0.000118	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—DRD4—conduct disorder	1.68e-05	0.000117	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—HTR2A—conduct disorder	1.68e-05	0.000117	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—DRD4—conduct disorder	1.66e-05	0.000116	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	1.66e-05	0.000116	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—HTR2A—conduct disorder	1.65e-05	0.000115	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—HTR2A—conduct disorder	1.63e-05	0.000114	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—COMT—conduct disorder	1.62e-05	0.000113	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—MAOA—conduct disorder	1.61e-05	0.000112	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—EP300—conduct disorder	1.57e-05	0.00011	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—HTR2A—conduct disorder	1.56e-05	0.000109	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	1.54e-05	0.000108	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—EP300—conduct disorder	1.54e-05	0.000108	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—HTR2A—conduct disorder	1.49e-05	0.000104	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—COMT—conduct disorder	1.48e-05	0.000104	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—MAOA—conduct disorder	1.47e-05	0.000103	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—HTR2A—conduct disorder	1.47e-05	0.000103	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—EP300—conduct disorder	1.34e-05	9.37e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—HTR2A—conduct disorder	1.34e-05	9.35e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	1.32e-05	9.26e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.28e-05	8.94e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.27e-05	8.89e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.24e-05	8.65e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.22e-05	8.51e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—EP300—conduct disorder	1.19e-05	8.34e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—EP300—conduct disorder	1.18e-05	8.29e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.12e-05	7.85e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.1e-05	7.71e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.1e-05	7.68e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.09e-05	7.66e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.08e-05	7.58e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.08e-05	7.56e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1e-05	7.03e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—EP300—conduct disorder	9.15e-06	6.4e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—EP300—conduct disorder	9.13e-06	6.39e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—EP300—conduct disorder	9.08e-06	6.35e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—EP300—conduct disorder	8.89e-06	6.22e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—EP300—conduct disorder	8.74e-06	6.12e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—EP300—conduct disorder	8.63e-06	6.04e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—EP300—conduct disorder	8.26e-06	5.78e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—EP300—conduct disorder	7.87e-06	5.51e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—EP300—conduct disorder	7.83e-06	5.48e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—EP300—conduct disorder	7.77e-06	5.44e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—EP300—conduct disorder	7.08e-06	4.95e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—EP300—conduct disorder	7.01e-06	4.91e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—EP300—conduct disorder	6.93e-06	4.85e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—EP300—conduct disorder	6.77e-06	4.74e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—EP300—conduct disorder	6.73e-06	4.71e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—EP300—conduct disorder	6.55e-06	4.58e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—EP300—conduct disorder	6.45e-06	4.51e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—EP300—conduct disorder	6.36e-06	4.45e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EP300—conduct disorder	5.94e-06	4.16e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EP300—conduct disorder	5.85e-06	4.09e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EP300—conduct disorder	5.84e-06	4.08e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EP300—conduct disorder	5.82e-06	4.07e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EP300—conduct disorder	5.8e-06	4.06e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EP300—conduct disorder	5.74e-06	4.02e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EP300—conduct disorder	5.73e-06	4.01e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EP300—conduct disorder	5.32e-06	3.72e-05	CbGpPWpGaD
